Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03841838 · ClinicalTrials.gov registry record · NA
The Effect of Energy Drink on Cardiovascular Variables: A Randomized Controlled Trial
A NA study, sponsored by University of the Pacific.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03841838: Completed NA study, sponsored by University of the Pacific.
NCT03841838 is a NA study that has completed, run by University of the Pacific. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03841838, a NA study, has completed, sponsored by University of the Pacific.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Many adults in the United States regularly consumer energy drinks. Currently, the safety of energy drinks is still questionable and there are many reports associating energy drinks with adverse events including hospitalizations and deaths. Previous research shows that energy drink can affect heart rhythm and elevate blood pressure. However, these studies use a higher volume (32 ounces) of energy drinks than those available in the market (24 ounces). The purpose of this study is to study if 24-ounce energy drinks can significantly affect heart rhythm and elevate blood pressure when compared to a placebo.
Primary Outcome
Maximum change in QTc interval from baseline in each of 2 arm
Interventions
- OTHER Energy drink
- OTHER Placebo drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-02-23 |
| Est. Completion | 2019-05-09 |
| Phase | NA |
What the finished NCT03841838 record still lists
NCT03841838 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Energy drink is the first listed.
NCT03841838 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03841838 about?
NCT03841838 is a clinical study titled "The Effect of Energy Drink on Cardiovascular Variables: A Randomized Controlled Trial". Many adults in the United States regularly consumer energy drinks. Currently, the safety of energy drinks is still questionable and there are many reports associating energy drinks with adverse events including hospitalizations and deaths. Previous research shows that energy drink can affect heart r...
What is the current status of trial NCT03841838?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-02-23. Estimated completion is 2019-05-09.
What interventions are being tested in trial NCT03841838?
The interventions under investigation include: Energy drink (OTHER), Placebo drink (OTHER).
Who is sponsoring clinical trial NCT03841838?
This trial is sponsored by University of the Pacific, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03841838's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI